R&D spending by the one thousand public companies that spend the most on R&D increased 5.7% last year to $532 billion, as operating profits declined 8.6% and sales grew 6.5%, according to the Booz & Company’s “Global Innovation 1000” report. R&D as a percentage of sales was flat at 3.6%. R&D spending by these companies […]

According to a report commissioned by the Coca-Cola Retailing Research Council Asia and prepared by McKinsey & Company, retailers in Asia should be more active in setting standards for food safety and freshness. To contain threats, retailers need a management framework for their entire supply chain. Retailers should also focus on so-called “hot spots,” where […]

Sunnyvale, CA 10/28/09—Symyx Technologies has announced the restructuring of its High Productivity Research business (HPR), resulting in the termination of 75 employees. The company will shut down its contract development and manufacturing operations that were acquired as part of its acquisition of contract service provider Integrity Biosolution last year (see IBO 8/15/09). Consequently, it will […]

Liege, Belgium 10/23/09—Reagent kit company Eurogentec SA has agreed to acquire AnaSpec, a supplier of peptides synthesis, labeled peptides and antibodies, fluorescent dyes and enzyme activity assays, for an undisclosed amount. “Our combined expertise enables Eurogentec to provide innovative solutions in the fields of Genomics and Proteomics for basic research in the biotech and pharmaceutical […]

Rockville, MD 10/19/09—Life science reagent supplier OriGene Technologies has acquired Marligen Biosciences for an undisclosed amount. OriGene is a provider of assays for the Luminex xMAP platform, as well as DNA and RNA purification kits. Maligen Bioscience provides assays for the study of gene regulation and genotyping, as well as plasmid purification kits and sample […]

San Diego, CA and Vienna, Austria 10/27/09—EBioscience, a supplier of cell analysis reagents, has acquired Bender MedSystems GmbH for an undisclosed amount in an all-cash transaction. Bender MedSystems GmbH is a supplier of more than 1,000 immunological research reagents and research diagnostics, including the Instant ELISA technology and FlowCytomix bead-based multiplexing technology. “Bender MedSystems provides […]

Toronto, Canada 10/20/09—MDS shareholders have approved the sale of the company’s Analytical Technologies business to Danaher for $650 million in cash (see IBO 9/15/09). More than 99% of the common shares voted approved the sale in a special meeting held on October 20. The sale remains subject to regulatory approval.